Sara M. Tolaney, MD, MPH
PeerRuben Mesa, MD, FACP
PeerNSCLC Therapy Management and Biomarker Testing
Mark Socinski, MD
PeerUnderstanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
Neeraj Agarwal, MD, FASCO
Peer